Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial

@article{Elwanis2009SurgicalTF,
  title={Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial},
  author={Mostafa E A Elwanis and Doaa Wadie Maximous and Mohamed Ibrahim Elsayed and Nabiel Nh Mikhail},
  journal={World Journal of Surgical Oncology},
  year={2009},
  volume={7},
  pages={52 - 52}
}
INTRODUCTION Treatment of rectal cancer requires a multidisciplinary approach with standardized surgical, pathological and radiotherapeutic procedures. Sphincter preserving surgery for cancer of the lower rectum needs a long-course of neoadjuvant treatments to reduce tumor volume, to induce down-staging that increases circumferential resection margin, and to facilitate surgery. AIM To evaluate the rate of anal sphincter preservation in low lying, resectable, locally advanced rectal cancer and… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Janjan N: A Phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients with locally advanced rectal cancer (LARC)

  • EH Lin, J Skibber, +7 authors JL Abbruzzese
  • J Clin Oncol 2005,
  • 2005
Highly Influential
7 Excerpts

Phase II study of preoperative chemoradiation with capcitabine in rectal cancer

  • J Dunst, T Reese, +6 authors A Hinke
  • Proc Am Soc Clin Oncol
  • 2004
Highly Influential
7 Excerpts

Similar Papers

Loading similar papers…